Our Services
Medical Information
Helpful Resources
Published on: 10/4/2026
A continuous glucose monitor (CGM) is a small wearable sensor, usually placed on the arm or abdomen, that measures glucose levels in the fluid under your skin every few minutes and sends readings to a phone, reader, or insulin pump, showing trends and alerts instead of single finger-stick numbers. CGMs are most often used by people with type 1 diabetes, people with type 2 diabetes on insulin or with frequent highs and lows, pregnant people with gestational diabetes, and sometimes those with prediabetes, reactive hypoglycemia, or unexplained fatigue, shakiness, and dizziness, though candidacy, accuracy limits, and insurance coverage vary by person. There are several important factors to consider, including when a CGM is medically necessary versus optional, so see below to understand more.
If you are experiencing symptoms like excessive thirst, frequent urination, blurred vision, sudden weight changes, or episodes of lightheadedness, those signs deserve attention before you decide whether glucose tracking is right for you. Take a free, instant, online symptom check to better understand what may be driving your symptoms and to clarify the next steps worth discussing with a clinician.
Last reviewed for medical accuracy: 10/02/2026
A continuous glucose monitor (CGM) is a small wearable device that measures your glucose (sugar) levels in real time throughout the day and night. Instead of relying solely on finger-stick tests, a CGM provides ongoing information about how your glucose changes with meals, exercise, stress and sleep. This helps you and your healthcare team make more informed decisions about meal choices, insulin dosing and lifestyle habits.
Sensor
Transmitter
Display Device
Calibration
Alerts & Alarms
| Type | Description | Examples |
|---|---|---|
| Real-Time CGM (rtCGM) | Continuously sends readings to your display device every 1–5 minutes. | Dexcom G6, Medtronic Guardian™4 |
| Intermittently Scanned CGM (isCGM) | Stores readings; you scan the sensor with a reader or smartphone to view data. | FreeStyle Libre 2 |
Reduced Finger Pricks
Fewer finger-stick tests for glucose checks (many systems are factory-calibrated).
Trend Insight
See how fast your glucose is rising or falling, helping you catch highs and lows before they become severe.
Alarms for Safety
Customizable low-glucose and high-glucose alerts can prevent dangerous episodes.
Data Sharing
Share real-time data with family, caregivers or your healthcare team for remote monitoring.
Improved Glycemic Control
Studies show that CGM use often leads to lower average glucose (A1C) and fewer hypoglycemic events.
Many people can benefit from continuous glucose monitoring, but certain groups are especially encouraged by professional guidelines:
Type 1 Diabetes
Type 2 Diabetes on Intensive Insulin Therapy
Frequent Hypoglycemia or Hypoglycemia Unawareness
Pregnant Women with Diabetes (Pre-existing or Gestational)
High Variability in Glucose Levels
Personal Preference
Prescription Requirement
A CGM requires a prescription from your healthcare provider.
Insurance
Out-of-Pocket Costs
Sensor Wear Time
Skin Reactions
Data Overload
Calibration & Maintenance
Talk to Your Healthcare Team
Set Realistic Goals
Learn to Act on Trends
Use Companion Apps
Review Data Regularly
A CGM is a powerful tool, but it works best as part of a broader self-care plan:
Continuous glucose monitors greatly reduce the need for finger-sticks, but they do not replace professional medical advice. If you experience:
—talk to a healthcare provider or seek emergency care right away.
Choosing and using a continuous glucose monitor involves personalized decisions about device selection, insurance coverage and data interpretation. Always speak to your doctor or diabetes care team before starting or changing any glucose monitoring strategy—especially if you have life-threatening or serious health concerns. Continuous glucose monitoring can be life-changing, but it works best when combined with professional guidance, education and support.
(References)
* Nansel TR, Anderson BJ, Laffel LM, Simons-Morton BG, Weissberg-Benchell J, Wysocki T, Iannotti RJ, Holmbeck GN, Hood KK, Lochrie AS. A multisite trial of a clinic-integrated intervention for promoting family management of pediatric type 1 diabetes: feasibility and design. Pediatr Diabetes. 2009 Apr;10(2):105-15. doi: 10.1111/j.1399-5448.2008.00448.x. Epub 2008 Aug 20. PMID: 18721167; PMCID: PMC2843426.
* Roberts R, Walsh J, Heinemann L. Help! Someone is beeping.. J Diabetes Sci Technol. 2014 Jul;8(4):627-9. doi: 10.1177/1932296814532882. Epub 2014 May 12. PMID: 24876435; PMCID: PMC4764223.
* El-Laboudi AH, Misra S, Martineau M, Deol P, Sanders A, Oliver N. Intentional Large Insulin Overdose Captured on a Continuous Glucose Monitor: A Novel Case Report. J Diabetes Sci Technol. 2015 Jul;9(4):929-31. doi: 10.1177/1932296815579691. Epub 2015 Apr 7. PMID: 25852072; PMCID: PMC4525655.
* Gehr B. [Is the era of blood glucose over? A clinical update to modern glucose sensors in diabetes (FGM, CGM)]. MMW Fortschr Med. 2019 Mar;161(4):53-58. doi: 10.1007/s15006-019-0227-z. PMID: 30830607.
* Argento NB. A Pandemic Forces United States to Leap Forward. J Diabetes Sci Technol. 2020 Jul;14(4):710-711. doi: 10.1177/1932296820929412. Epub 2020 Jun 2. PMID: 32486843; PMCID: PMC7673155.
* Attaye I, van der Vossen EWJ, Mendes Bastos DN, Nieuwdorp M, Levin E. Introducing the Continuous Glucose Data Analysis (CGDA) R Package: An Intuitive Package to Analyze Continuous Glucose Monitoring Data. J Diabetes Sci Technol. 2022 May;16(3):783-785. doi: 10.1177/19322968211070293. Epub 2022 Jan 19. PMID: 35043702; PMCID: PMC9294587.
* Kieu A, King J, Govender RD, Östlundh L. The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review. J Diabetes Sci Technol. 2023 May;17(3):762-774. doi: 10.1177/19322968211070855. Epub 2022 Feb 1. PMID: 35100891; PMCID: PMC10210096.
* Soto-Hernaez J, McCrimmon RJ, Pearson ER, Soto-Pedre E. Real-world initiation of continuous glucose monitoring (CGM) in adults with type 1 diabetes leads to increased body mass index - A brief report from IMI-SOPHIA study. J Diabetes Complications. 2025 Aug;39(8):109089. doi: 10.1016/j.jdiacomp.2025.109089. Epub 2025 May 24. PMID: 40435567.
* Harris R, Guariglia C, Cunningham A. Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes in Primary Care: Cross-Sectional Survey of Provider Comfort. JMIR Form Res. 2026 Jun 4;10:e92196. doi: 10.2196/92196. Epub 2026 Jun 4. PMID: 42241316; PMCID: PMC13235701.
* Trawley SL, McAuley SA, Stephens AN. Continuous Glucose Monitoring and Hypoglycemia Detection while Driving: Results from a Cross-Sectional Survey. Diabetes Technol Ther. 2026 Jul;28(7):746-753. doi: 10.1177/15209156251408410. Epub 2025 Dec 24. PMID: 42381170.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.